Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Rheumatology

  • 1
    News

    COVID-19: Frequently asked clinical questions

    April 24, 2020

    Should I continue to vaccinate my pediatric population during peak COVID-19?

  • 1
    News

    Latest data on COVID-19 patients with rheumatic diseases revealed in registry

    April 23, 2020

    Data for a total of 583 COVID-19 patients have now been made available.

  • 1
    News

    ‘We’re in great distress here,’ infusion center CMO says

    April 10, 2020

    Thrivewell is also deploying a mobile infusion unit to recovered COVID-19 patients who require an infusion for their autoimmune disease.

  • 1
    News

    Infusion center directors shuffle treatment services in the era of COVID-19

    April 10, 2020

    “We look for ways to try to reassure patients and to comfort them, and work with them to make the best of the situation,” Dr. Christopher R. Phillips said.

  • News

    Treatment for RA, SpA may not affect COVID-19 severity

    April 8, 2020

    A small study in Italy saw no apparent worsening of COVID-19 symptoms among people treated for RA or spondyloarthritis.

  • 1
    News

    Rheumatologists seek to reassure amid hydroxychloroquine shortage

    March 26, 2020

    Rheumatologists Jill P. Buyon and Peter M. Izmirly answer questions about the availability of hydroxychloroquine during the COVID-19 pandemic, and rheumatologist Michael H. Pillinger discusses the prospects for a new trial of the gout drug colchicine in COVID-19 patients.

  • News

    Amid hydroxychloroquine hopes, lupus patients face shortages

    March 23, 2020

    Pharmacists are reporting depleted stocks of the drug, leaving many of the roughly 1.5 million lupus patients across the country unable to get their prescriptions filled. They now face an uncertain future as the public clings to one of the first signs of hope to appear since the coronavirus began sweeping across the U.S.

  • 1
    News

    Rheumatologists to share knowledge in COVID-19 patient-centered registry

    March 19, 2020

    The soon-to-be launched registry will help guide clinicians in the treatment of patients with rheumatologic disorders treated with immunosuppressive medications.

  • 1
    News

    Large population-based study underscores link between gout, CVD event risk

    November 23, 2019

    ATLANTA – The relationships between gout and fatal and nonfatal CVD events found in a large population-based health data linkage study in New Zealand were not ameliorated by allopurinol use or serum urate lowering to treatment target.

  • News

    Almost one-third of ED patients with gout are prescribed opioids

    July 3, 2019

    A diagnosis of diabetes or polyarticular gout attack, and prior opioid use were all associated with a more than 100% higher odds of opioid prescription.

Previous1 … 4 5 6 7Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences